Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
TSX:VPH
Price:
0.1 CAD
Market Closed
Updated:
May 18, 2024
Valeo Pharma Inc
Operating Expenses
|
Valeo Pharma Inc
Operating Expenses Peer Comparison
Comparables:
BHC
TH
K
GUD
EDT
CPH
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
Operating Expenses
-CA$30.3m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Operating Expenses
-$4.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-4%
|
|
|
Theratechnologies Inc
TSX:TH
|
Operating Expenses
-$65.3m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-18%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Operating Expenses
-CA$146.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Operating Expenses
-CA$12.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
1%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Operating Expenses
-$7.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
14%
|
CAGR 10-Years
2%
|
See Also
What is Valeo Pharma Inc's Operating Expenses?
Operating Expenses
-30.3m
CAD
-30.3m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Operating Expenses amounts to -30.3m CAD.
What is Valeo Pharma Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-56%
-56%
Over the last year, the Operating Expenses growth was -19%. The average annual Operating Expenses growth rates for Valeo Pharma Inc have been -75% over the past three years , -56% over the past five years .
You don't have any saved screeners yet
